Toxicology – Syrup of Ipecac

Core Concept

Syrup of ipecac is an oral emetic that was historically used to induce vomiting after poisoning.

It contains the alkaloids:

• Emetine
• Cephaeline

Although once widely kept in homes and used for gastrointestinal decontamination, ipecac has essentially no role in modern routine poisoning management.

The central modern principle is:

Do not induce vomiting after a poisoning unless specifically directed in an exceptional circumstance by a medical toxicologist or poison center.

⸻

Mechanism of Action

Ipecac produces vomiting through both central and peripheral mechanisms.

Central effect

Cephaeline and related alkaloids stimulate pathways involved in the vomiting response.

Gastrointestinal effect

Emetine and cephaeline irritate the gastrointestinal tract and stimulate visceral afferent pathways.

The result is:

Nausea → retching → repeated vomiting

Vomiting can persist well beyond the initial episode.

⸻

Historical Rationale

Ipecac was originally intended to remove poison from the stomach before substantial absorption occurred.

The theory was:

Ingestion → induce vomiting → expel stomach contents → reduce systemic absorption

However, producing vomiting does not reliably empty the stomach.

Clinical studies failed to demonstrate that routine ipecac administration improves meaningful outcomes after poisoning.

⸻

Why Ipecac Was Abandoned

Routine use declined because:

• It does not reliably remove enough toxin to improve outcomes.
• Vomiting may be delayed.
• Poison absorption continues while waiting for emesis.
• Vomiting can persist.
• Aspiration can occur.
• It may delay activated charcoal or antidotes.
• It can interfere with transport and emergency evaluation.
• Patients may deteriorate neurologically while vomiting.

Therefore:

Routine home, prehospital, emergency-department, and pediatric use is no longer recommended.

⸻

Prehospital Poisoning

The older recommendation to administer ipecac when a patient is far from a healthcare facility is obsolete.

Modern priorities are:

• Contact an appropriate poison-information service or emergency service
• Assess airway, breathing, and circulation
• Identify the substance, amount, and time of exposure
• Follow substance-specific advice
• Arrange appropriate medical assessment when indicated

Distance from a hospital does not by itself justify induced vomiting.

⸻

Pediatric Poisoning

Ipecac was once especially common in pediatric poisonings.

Modern practice specifically moved away from this approach.

Parents and caregivers should not routinely induce vomiting in a child after ingestion.

Children can deteriorate unexpectedly, and vomiting increases the risk of aspiration.

⸻

Caustic Ingestion

Ipecac must not be used after ingestion of corrosive substances such as strong acids or alkalis.

Vomiting would re-expose the:

• Esophagus
• Pharynx
• Mouth
• Airway

to the corrosive material.

This can worsen tissue injury and increase aspiration risk.

⸻

Hydrocarbon Ingestion

Vomiting is particularly undesirable after many hydrocarbon exposures.

Examples include products such as:

• Kerosene
• Gasoline
• Lamp oil
• Some petroleum distillates

The major danger is often pulmonary aspiration, rather than systemic absorption from the gastrointestinal tract.

Inducing vomiting can markedly increase the opportunity for hydrocarbon to enter the lungs.

⸻

Sharp Objects

Vomiting should not be induced after ingestion of:

• Sharp objects
• Jagged foreign bodies
• Other material capable of mechanically injuring the gastrointestinal tract

Forced retrograde movement can cause additional injury.

⸻

Patient With Impaired Consciousness

Ipecac should not be administered when airway protection is impaired.

This includes patients with:

• Significant sedation
• Coma
• Severe confusion
• Loss of protective airway reflexes

Vomiting in these circumstances creates substantial aspiration risk.

⸻

Expected Neurologic Deterioration

Ipecac is also dangerous when the ingested substance may soon produce:

• Seizures
• Rapid sedation
• Coma
• Severe agitation

A patient who is initially awake may lose airway protection while vomiting.

This is one reason poisoning management cannot be based solely on the patient’s initial appearance.

⸻

Persistent Vomiting

The most common adverse effect is prolonged nausea and vomiting.

Consequences can include:

• Dehydration
• Electrolyte abnormalities
• Difficulty administering oral treatments
• Delayed medical care
• Aspiration

Persistent vomiting can also confuse assessment because it may be attributed incorrectly to the original poison.

⸻

Aspiration

Aspiration is one of the most clinically important complications.

Vomited material can enter the respiratory tract and cause:

• Chemical pneumonitis
• Airway obstruction
• Hypoxemia
• Respiratory failure

Risk is particularly high with hydrocarbons and impaired consciousness.

⸻

Mechanical Complications of Forceful Vomiting

Repeated forceful emesis can occasionally cause:

• Mallory-Weiss mucosal tears
• Gastrointestinal bleeding
• Esophageal injury
• Pneumomediastinum
• Rare serious thoracic complications

These risks further weaken any rationale for routine induced vomiting.

⸻

Cardiovascular Effects

Forceful vomiting can produce substantial vagal stimulation.

Possible consequences include:

• Bradycardia
• Presyncope
• Syncope

More importantly, chronic exposure to ipecac can produce direct cardiotoxicity from emetine.

⸻

Chronic Ipecac Abuse

Repeated or prolonged ipecac use can cause serious systemic toxicity.

Emetine accumulates in tissues and can injure:

• Cardiac muscle
• Skeletal muscle

Potential manifestations include:

• Progressive weakness
• Myopathy
• Cardiomyopathy
• Dysrhythmias
• Heart failure
• Electrolyte abnormalities

Severe chronic toxicity can be fatal.

⸻

Eating Disorders and Ipecac

Historically, chronic ipecac misuse occurred in some patients attempting to induce vomiting repeatedly.

This is medically dangerous because emetine toxicity can persist even after use stops.

Unexplained:

• Proximal muscle weakness
• Cardiomyopathy
• Dysrhythmias
• Persistent gastrointestinal symptoms

may warrant consideration of chronic emetine exposure when clinically appropriate.

⸻

Activated Charcoal

Ipecac should not be given simply as preparation for activated charcoal.

Vomiting can:

• Delay charcoal administration
• Cause charcoal to be vomited
• Increase aspiration risk

Activated charcoal itself is now used only for selected adsorbable poisonings when anticipated benefit outweighs risk.

⸻

Antidote Administration

Induced vomiting may interfere with orally administered therapies.

For example, repeated vomiting can prevent reliable delivery or retention of an oral antidote or other necessary medication.

Modern management prioritizes effective, toxin-specific treatment rather than attempting routine emesis first.

⸻

Ipecac vs Gastric Lavage

The older source suggests choosing gastric lavage instead of ipecac in many circumstances.

This also requires modernization:

Neither ipecac nor gastric lavage is routinely recommended for poisoned patients.

Gastric lavage now has, at most, a very narrow role in exceptional potentially life-threatening exposures when performed early by experienced clinicians with appropriate airway protection.

It is not the routine replacement for ipecac.

⸻

Large Tablets and Plant Material

Older practice suggested ipecac for large tablets or plant material that might not pass through a lavage tube.

This is no longer a routine indication.

Management instead depends on:

• Specific toxin
• Toxicity of the exposure
• Time since ingestion
• Formulation
• Gastrointestinal function
• Imaging when relevant
• Availability of more appropriate decontamination or elimination strategies

⸻

Whole-Bowel Irrigation

For selected situations involving material poorly managed by activated charcoal, whole-bowel irrigation may occasionally be considered.

Examples can include selected:

• Sustained-release preparations
• Enteric-coated drugs
• Iron or certain other poorly adsorbed substances
• Drug packets

This is a specialist-directed intervention and does not create a modern role for ipecac.

⸻

Pregnancy

The historical FDA pregnancy letter-category system is obsolete.

More importantly, because ipecac itself has essentially no routine therapeutic role in poisoning, pregnancy rarely creates a situation in which its potential benefits need to be weighed.

Management should instead use appropriate substance-specific supportive and antidotal treatment.

⸻

Ipecac Toxicity

If ipecac itself has been consumed excessively, management is primarily supportive.

Evaluation may include:

• Hydration status
• Electrolytes
• ECG
• Cardiac function when chronic exposure is suspected
• Assessment for aspiration
• Evaluation of muscle weakness

There is no specific antidote for emetine toxicity.

⸻

Modern Gastrointestinal Decontamination Principle

Poison management has shifted away from:

“Remove everything from the stomach.”

Instead, clinicians ask:

• What substance was ingested?
• How toxic is the amount?
• Has it already been absorbed?
• Will decontamination meaningfully change outcome?
• Does the intervention create more risk than benefit?

For most poisonings, supportive care and specific antidotes are more important than gastric emptying.

⸻

Important Modernization of the Older Source

• Syrup of ipecac is an emetic containing emetine and cephaeline.
• It was historically used to induce vomiting after poisoning.
• Routine ipecac administration is obsolete.
• It should not routinely be kept or used as a home poisoning treatment.
• Being far from a healthcare facility is no longer an indication for ipecac.
• Small patient size is not an indication.
• Large tablets or plant material do not create a routine indication.
• Ipecac has not been shown to improve clinically meaningful outcomes in poisoning.
• It can delay activated charcoal, antidotes, transportation, and definitive medical care.
• It is particularly dangerous after caustic or hydrocarbon ingestion.
• It should not be used when consciousness may deteriorate or seizures may occur.
• Persistent vomiting and aspiration are important complications.
• Chronic ipecac exposure can cause emetine-associated myopathy and cardiomyopathy.
• Gastric lavage is not the routine modern alternative to ipecac; lavage itself has only rare, highly selected indications.
• Historical pregnancy categories are obsolete.
• Routine dosing instructions for inducing emesis are no longer clinically appropriate.

⸻

Key Points

• Ipecac induces vomiting through central and gastrointestinal actions of emetine and cephaeline.
• It was once widely used for gastrointestinal decontamination.
• It is no longer recommended routinely for poisoning.
• Clinical benefit has not been demonstrated, while important harms are possible.
• Never routinely induce vomiting after a poisoning.
• Caustic ingestion is especially unsuitable because vomiting can cause repeat corrosive injury.
• Hydrocarbon ingestion is especially unsuitable because vomiting increases aspiration risk.
• Ipecac is unsafe when consciousness may deteriorate or seizures are possible.
• Persistent vomiting can cause dehydration, aspiration, and delays in effective therapy.
• Chronic ipecac misuse can produce serious cardiomyopathy and skeletal myopathy.
• Gastric lavage has not replaced ipecac as routine treatment; it too is reserved for exceptional situations.
• Modern poisoning management emphasizes supportive care, selected activated charcoal, specific antidotes, and toxin-directed treatment rather than induced emesis.